193 related articles for article (PubMed ID: 10731058)
1. Sirolimus in pediatric gastrointestinal transplantation: the use of sirolimus for pediatric transplant patients with tacrolimus-related cardiomyopathy.
Pappas PA; Weppler D; Pinna AD; Rusconi P; Thompson JF; Jaffe JS; Tzakis AG
Pediatr Transplant; 2000 Feb; 4(1):45-9. PubMed ID: 10731058
[TBL] [Abstract][Full Text] [Related]
2. Reversal of tacrolimus-related hypertrophic cardiomyopathy after conversion to rapamycin in a pediatric liver transplant recipient.
Turska-Kmieć A; Jankowska I; Pawłowska J; Kaliciński P; Kawalec W; Tomyn M; Markiewicz M; Teisseyre J; Czubkowski P; Rekawek J; Socha J
Pediatr Transplant; 2007 May; 11(3):319-23. PubMed ID: 17430490
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes in pediatric liver recipients: comparison between cyclosporin A and tacrolimus.
Cao S; Cox KL; Berquist W; Hayashi M; Concepcion W; Hammes GB; Ojogho OK; So SK; Frerker M; Castillo RO; Monge H; Esquivel CO
Pediatr Transplant; 1999 Feb; 3(1):22-6. PubMed ID: 10359027
[TBL] [Abstract][Full Text] [Related]
4. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
[TBL] [Abstract][Full Text] [Related]
5. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
Gruessner RW
Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
[TBL] [Abstract][Full Text] [Related]
6. Reversal of tacrolimus-related hypertrophic obstructive cardiomyopathy 5 years after kidney transplant in a 6-year-old recipient.
Jarzembowski TM; John E; Panaro F; Manzelli A; Cabrera A; Greco A; Varga P; Sankary H; Testa G; Benedetti E
Pediatr Transplant; 2005 Feb; 9(1):117-21. PubMed ID: 15667624
[TBL] [Abstract][Full Text] [Related]
7. Sirolimus for rescue and primary immunosuppression in transplanted children receiving tacrolimus.
Sindhi R; Webber S; Venkataramanan R; McGhee W; Phillips S; Smith A; Baird C; Iurlano K; Mazariegos G; Cooperstone B; Holt DW; Zeevi A; Fung JJ; Reyes J
Transplantation; 2001 Sep; 72(5):851-5. PubMed ID: 11571449
[TBL] [Abstract][Full Text] [Related]
8. Replacing calcineurin inhibitors with mTOR inhibitors in children.
Sindhi R; Seward J; Mazariegos G; Soltys K; Seward L; Smith A; Kosmach B; Venkataramanan R
Pediatr Transplant; 2005 Jun; 9(3):391-7. PubMed ID: 15910398
[TBL] [Abstract][Full Text] [Related]
9. Tacrolimus: the good, the bad, and the ugly.
Chand DH; Southerland SM; Cunningham RJ
Pediatr Transplant; 2001 Feb; 5(1):32-6. PubMed ID: 11260486
[TBL] [Abstract][Full Text] [Related]
10. Long-term results after conversion from cyclosporine to tacrolimus in pediatric liver transplantation for acute and chronic rejection.
Reyes J; Jain A; Mazariegos G; Kashyap R; Green M; Iurlano K; Fung J
Transplantation; 2000 Jun; 69(12):2573-80. PubMed ID: 10910279
[TBL] [Abstract][Full Text] [Related]
11. Sirolimus conversion in liver transplant recipients with calcineurin inhibitor-induced complications: efficacy and safety.
Ju WQ; Guo ZY; Liang WH; Wu LW; Tai Q; Hu AB; Han M; Zhu XF; He X
Exp Clin Transplant; 2012 Apr; 10(2):132-5. PubMed ID: 22432756
[TBL] [Abstract][Full Text] [Related]
12. Renal function improves in liver transplant recipients when switched from a calcineurin inhibitor to sirolimus.
Fairbanks KD; Eustace JA; Fine D; Thuluvath PJ
Liver Transpl; 2003 Oct; 9(10):1079-85. PubMed ID: 14526403
[TBL] [Abstract][Full Text] [Related]
13. Conversion to sirolimus-based maintenance immunosuppression using daclizumab bridge therapy in renal transplant recipients.
Sundberg AK; Rohr MS; Hartmann EL; Adams PL; Stratta RJ
Clin Transplant; 2004; 18 Suppl 12():61-6. PubMed ID: 15217410
[TBL] [Abstract][Full Text] [Related]
14. Orthotopic liver transplantation using low-dose tacrolimus and sirolimus.
McAlister VC; Peltekian KM; Malatjalian DA; Colohan S; MacDonald S; Bitter-Suermann H; MacDonald AS
Liver Transpl; 2001 Aug; 7(8):701-8. PubMed ID: 11510015
[TBL] [Abstract][Full Text] [Related]
15. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
[TBL] [Abstract][Full Text] [Related]
16. Sirolimus immunosuppression in pediatric heart transplant recipients: a single-center experience.
Lobach NE; Pollock-Barziv SM; West LJ; Dipchand AI
J Heart Lung Transplant; 2005 Feb; 24(2):184-9. PubMed ID: 15701435
[TBL] [Abstract][Full Text] [Related]
17. Conversion from tacrolimus to sirolimus as a treatment modality in de novo allergies and immune-mediated disorders in pediatric liver transplant recipients.
Kehar M; Grunebaum E; Jimenez-Rivera C; Mozer-Glassberg Y; Jamal A; Ng VL; Avitzur Y
Pediatr Transplant; 2020 Sep; 24(6):e13737. PubMed ID: 32428390
[TBL] [Abstract][Full Text] [Related]
18. Tacrolimus related hypertrophic cardiomyopathy in liver transplant recipients.
Dehghani SM; Haghighat M; Imanieh MH; Zahmatkeshan M; Borzooei M; Amoozegar H; Zamirian M; Gholami S; Bahador A; Nikeghbalian S; Salahi H; Malek-Hosseini SA
Arch Iran Med; 2010 Mar; 13(2):116-9. PubMed ID: 20187665
[TBL] [Abstract][Full Text] [Related]
19. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
[TBL] [Abstract][Full Text] [Related]
20. Echocardiographic findings of hypertrophic cardiomyopathy in children after orthotopic liver transplantation.
Chang RK; McDiarmid SV; Alejos JC; Drant SE; Klitzner TS
Pediatr Transplant; 2001 Jun; 5(3):187-91. PubMed ID: 11422821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]